Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03899155
Title Pan Tumor Nivolumab Rollover Study
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

cancer

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.